Table 4.
Literature on bare cobalt-chromium coronary stents.
| Stent type | Follow-up duration (months) | Patients (n) | Procedural success (%) | TLR (%) | TVR (%) | MACE (%) | TVF (%) | Stent thrombosis (%) |
|---|---|---|---|---|---|---|---|---|
| MultiLink Vision17 | 6 | 268 | 99.0 | 4.3 | 5.1 | 6.2 | 6.7 | - |
| Medtronic Driver35 | 9 | 298 | 98.3 | 7.0 | 8.1 | 8.4 | 8.1 | 0 |
| Medtronic Driver36 | 6 | 202 | 98.0 | 9.4 | - | 12.4 | - | 0.5 |
| Arthos Pico37 | 12 | 203 | 98.0 | - | 8.9 | 15.0 | - | 2.0 |
| Invatec Skylor38 | 9 | 150 | 97.0 | 6.0 | - | 8.0 | 12.4 | 1.4 |
MACE=major adverse cardiac event, TLR=target lesion revascularisation, TVF=target vessel failure, TVR=target vessel revascularisation. Each endpoint was defined according to the specific study.